1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Radiopharmaceutical Consumption 2016-2026

2.1.2 Radiopharmaceutical Consumption CAGR by Region

2.2 Radiopharmaceutical Segment by Type

2.2.1 Actinium-225

2.2.2 Lutetium-177

2.2.3 Radium-223

2.2.4 Holmium-166

2.2.5 Other

2.3 Radiopharmaceutical Sales by Type

2.3.1 Global Radiopharmaceutical Sales Market Share by Type (2016-2021)

2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2016-2021)

2.3.3 Global Radiopharmaceutical Sale Price by Type (2016-2021)

2.4 Radiopharmaceutical Segment by Application

2.4.1 Oncology

2.4.2 Cardiology

2.4.3 Other

2.5 Radiopharmaceutical Sales by Application

2.5.1 Global Radiopharmaceutical Sale Market Share by Application (2016-2021)

2.5.2 Global Radiopharmaceutical Revenue and Market Share by Application (2016-2021)

2.5.3 Global Radiopharmaceutical Sale Price by Application (2016-2021)

3 Global Radiopharmaceutical by Company

3.1 Global Radiopharmaceutical Sales Market Share by Company

3.1.1 Global Radiopharmaceutical Sales by Company (2019-2021)

3.1.2 Global Radiopharmaceutical Sales Market Share by Company (2019-2021)

3.2 Global Radiopharmaceutical Revenue Market Share by Company

3.2.1 Global Radiopharmaceutical Revenue by Company (2019-2021)

3.2.2 Global Radiopharmaceutical Revenue Market Share by Company (2019-2021)

3.3 Global Radiopharmaceutical Sale Price by Company

3.4 Global Manufacturers Radiopharmaceutical Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Radiopharmaceutical Product Location Distribution

3.4.2 Players Radiopharmaceutical Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Radiopharmaceutical by Region

4.1 Global Radiopharmaceutical by Region

4.1.1 Global Radiopharmaceutical Sales by Region

4.1.2 Global Radiopharmaceutical Revenue by Region

4.2 Americas Radiopharmaceutical Sales Growth

4.3 APAC Radiopharmaceutical Sales Growth

4.4 Europe Radiopharmaceutical Sales Growth

4.5 Middle East & Africa Radiopharmaceutical Sales Growth

5 Americas

5.1 Americas Radiopharmaceutical Sales by Country

5.1.1 Americas Radiopharmaceutical Sales by Country (2016-2021)

5.1.2 Americas Radiopharmaceutical Revenue by Country (2016-2021)

5.2 Americas Radiopharmaceutical Sales by Type

5.3 Americas Radiopharmaceutical Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Radiopharmaceutical Sales by Region

6.1.1 APAC Radiopharmaceutical Sales by Region (2016-2021)

6.1.2 APAC Radiopharmaceutical Revenue by Region (2016-2021)

6.2 APAC Radiopharmaceutical Sales by Type

6.3 APAC Radiopharmaceutical Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Radiopharmaceutical by Country

7.1.1 Europe Radiopharmaceutical Sales by Country (2016-2021)

7.1.2 Europe Radiopharmaceutical Revenue by Country (2016-2021)

7.2 Europe Radiopharmaceutical Sales by Type

7.3 Europe Radiopharmaceutical Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Radiopharmaceutical by Country

8.1.1 Middle East & Africa Radiopharmaceutical Sales by Country (2016-2021)

8.1.2 Middle East & Africa Radiopharmaceutical Revenue by Country (2016-2021)

8.2 Middle East & Africa Radiopharmaceutical Sales by Type

8.3 Middle East & Africa Radiopharmaceutical Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Radiopharmaceutical Distributors

10.3 Radiopharmaceutical Customer

11 Global Radiopharmaceutical Market Forecast

11.1 Global Radiopharmaceutical Forecast by Region

11.1.1 Global Radiopharmaceutical Forecast by Regions (2021-2026)

11.2.2 Global Radiopharmaceutical Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Radiopharmaceutical Forecast by Type

11.7 Global Radiopharmaceutical Forecast by Application

12 Key Players Analysis

12.1 Bracco Imaging

12.1.1 Bracco Imaging Company Information

12.1.2 Bracco Imaging Radiopharmaceutical Product Offered

12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Bracco Imaging Main Business Overview

12.1.5 Bracco Imaging Latest Developments

12.2 Bayer

12.2.1 Bayer Company Information

12.2.2 Bayer Radiopharmaceutical Product Offered

12.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Bayer Main Business Overview

12.2.5 Bayer Latest Developments

12.3 Mallinckrodt

12.3.1 Mallinckrodt Company Information

12.3.2 Mallinckrodt Radiopharmaceutical Product Offered

12.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Mallinckrodt Main Business Overview

12.3.5 Mallinckrodt Latest Developments

12.4 Nordion

12.4.1 Nordion Company Information

12.4.2 Nordion Radiopharmaceutical Product Offered

12.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Nordion Main Business Overview

12.4.5 Nordion Latest Developments

12.5 Triad Isotopes

12.5.1 Triad Isotopes Company Information

12.5.2 Triad Isotopes Radiopharmaceutical Product Offered

12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Triad Isotopes Main Business Overview

12.5.5 Triad Isotopes Latest Developments

12.6 Lantheus

12.6.1 Lantheus Company Information

12.6.2 Lantheus Radiopharmaceutical Product Offered

12.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Lantheus Main Business Overview

12.6.5 Lantheus Latest Developments

12.7 IBA Group

12.7.1 IBA Group Company Information

12.7.2 IBA Group Radiopharmaceutical Product Offered

12.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 IBA Group Main Business Overview

12.7.5 IBA Group Latest Developments

12.8 GE Healthcare

12.8.1 GE Healthcare Company Information

12.8.2 GE Healthcare Radiopharmaceutical Product Offered

12.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 GE Healthcare Main Business Overview

12.8.5 GE Healthcare Latest Developments

12.9 China Isotope & Radiation

12.9.1 China Isotope & Radiation Company Information

12.9.2 China Isotope & Radiation Radiopharmaceutical Product Offered

12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 China Isotope & Radiation Main Business Overview

12.9.5 China Isotope & Radiation Latest Developments

12.10 Jubilant Pharma

12.10.1 Jubilant Pharma Company Information

12.10.2 Jubilant Pharma Radiopharmaceutical Product Offered

12.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Jubilant Pharma Main Business Overview

12.10.5 Jubilant Pharma Latest Developments

12.11 Eli Lilly

12.11.1 Eli Lilly Company Information

12.11.2 Eli Lilly Radiopharmaceutical Product Offered

12.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Eli Lilly Main Business Overview

12.11.5 Eli Lilly Latest Developments

12.12 Advanced Accelerator Applications

12.12.1 Advanced Accelerator Applications Company Information

12.12.2 Advanced Accelerator Applications Radiopharmaceutical Product Offered

12.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Advanced Accelerator Applications Main Business Overview

12.12.5 Advanced Accelerator Applications Latest Developments

12.13 SIEMENS

12.13.1 SIEMENS Company Information

12.13.2 SIEMENS Radiopharmaceutical Product Offered

12.13.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 SIEMENS Main Business Overview

12.13.5 SIEMENS Latest Developments

12.14 Dongcheng

12.14.1 Dongcheng Company Information

12.14.2 Dongcheng Radiopharmaceutical Product Offered

12.14.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Dongcheng Main Business Overview

12.14.5 Dongcheng Latest Developments

12.15 Navidea

12.15.1 Navidea Company Information

12.15.2 Navidea Radiopharmaceutical Product Offered

12.15.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Navidea Main Business Overview

12.15.5 Navidea Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Radiopharmaceutical Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Actinium-225

Table 3. Major Players of Lutetium-177

Table 4. Major Players of Radium-223

Table 5. Major Players of Holmium-166

Table 6. Major Players of Other

Table 7. Global Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)

Table 8. Global Radiopharmaceutical Sales Market Share by Type (2016-2021)

Table 9. Global Radiopharmaceutical Revenue by Type (2016-2021) & ($ million)

Table 10. Global Radiopharmaceutical Revenue Market Share by Type (2016-2021)

Table 11. Global Radiopharmaceutical Sale Price by Type (2016-2021)

Table 12. Global Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)

Table 13. Global Radiopharmaceutical Sales Market Share by Application (2016-2021)

Table 14. Global Radiopharmaceutical Value by Application (2016-2021)

Table 15. Global Radiopharmaceutical Revenue Market Share by Application (2016-2021)

Table 16. Global Radiopharmaceutical Sale Price by Application (2016-2021)

Table 17. Global Radiopharmaceutical Sales by Company (2019-2021) & (M Doses)

Table 18. Global Radiopharmaceutical Sales Market Share by Company (2019-2021)

Table 19. Global Radiopharmaceutical Revenue by Company (2019-2021) ($ Millions)

Table 20. Global Radiopharmaceutical Revenue Market Share by Company (2019-2021)

Table 21. Global Radiopharmaceutical Sale Price by Company (2019-2021)

Table 22. Key Manufacturers Radiopharmaceutical Producing Area Distribution and Sales Area

Table 23. Players Radiopharmaceutical Products Offered

Table 24. Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Radiopharmaceutical Sales by Region (2016-2021) (M Doses)

Table 28. Global Radiopharmaceutical Sales Market Share by Region (2016-2021)

Table 29. Global Radiopharmaceutical Revenue by Region (2016-2021) & ($ Millions)

Table 30. Global Radiopharmaceutical Revenue Market Share by Region (2016-2021)

Table 31. Americas Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)

Table 32. Americas Radiopharmaceutical Sales Market Share by Country (2016-2021)

Table 33. Americas Radiopharmaceutical Revenue by Country (2016-2021) & ($ Millions)

Table 34. Americas Radiopharmaceutical Revenue Market Share by Country (2016-2021)

Table 35. Americas Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)

Table 36. Americas Radiopharmaceutical Sales Market Share by Type (2016-2021)

Table 37. Americas Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)

Table 38. Americas Radiopharmaceutical Sales Market Share by Application (2016-2021)

Table 39. APAC Radiopharmaceutical Sales by Region (2016-2021) & (M Doses)

Table 40. APAC Radiopharmaceutical Sales Market Share by Region (2016-2021)

Table 41. APAC Radiopharmaceutical Revenue by Region (2016-2021) & ($ Millions)

Table 42. APAC Radiopharmaceutical Revenue Market Share by Region (2016-2021)

Table 43. APAC Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)

Table 44. APAC Radiopharmaceutical Sales Market Share by Type (2016-2021)

Table 45. APAC Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)

Table 46. APAC Radiopharmaceutical Sales Market Share by Application (2016-2021)

Table 47. Europe Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)

Table 48. Europe Radiopharmaceutical Sales Market Share by Country (2016-2021)

Table 49. Europe Radiopharmaceutical Revenue by Country (2016-2021) & ($ Millions)

Table 50. Europe Radiopharmaceutical Revenue Market Share by Country (2016-2021)

Table 51. Europe Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)

Table 52. Europe Radiopharmaceutical Sales Market Share by Type (2016-2021)

Table 53. Europe Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)

Table 54. Europe Radiopharmaceutical Sales Market Share by Application (2016-2021)

Table 55. Middle East & Africa Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)

Table 56. Middle East & Africa Radiopharmaceutical Sales Market Share by Country (2016-2021)

Table 57. Middle East & Africa Radiopharmaceutical Revenue by Country (2016-2021) & ($ Millions)

Table 58. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country (2016-2021)

Table 59. Middle East & Africa Radiopharmaceutical Sales by Type (2016-2021) & (M Doses)

Table 60. Middle East & Africa Radiopharmaceutical Sales Market Share by Type (2016-2021)

Table 61. Middle East & Africa Radiopharmaceutical Sales by Application (2016-2021) & (M Doses)

Table 62. Middle East & Africa Radiopharmaceutical Sales Market Share by Application (2016-2021)

Table 63. Key and Potential Regions of Radiopharmaceutical

Table 64. Key Application and Potential Industries of Radiopharmaceutical

Table 65. Key Challenges of Radiopharmaceutical

Table 66. Key Trends of Radiopharmaceutical

Table 67. Radiopharmaceutical Distributors List

Table 68. Radiopharmaceutical Customer List

Table 69. Global Radiopharmaceutical Sales Forecast by Region (2021-2026) & (M Doses)

Table 70. Global Radiopharmaceutical Consumption Market Forecast by Region

Table 71. Global Radiopharmaceutical Revenue Forecast by Region (2021-2026) & ($ millions)

Table 72. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2021-2026)

Table 73. Americas Radiopharmaceutical Sales Forecast by Country (2021-2026) & (M Doses)

Table 74. Americas Radiopharmaceutical Revenue Forecast by Country (2021-2026) & ($ millions)

Table 75. APAC Radiopharmaceutical Sales Forecast by Region (2021-2026) & (M Doses)

Table 76. APAC Radiopharmaceutical Revenue Forecast by Region (2021-2026) & ($ millions)

Table 77. Europe Radiopharmaceutical Sales Forecast by Country (2021-2026) & (M Doses)

Table 78. Europe Radiopharmaceutical Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Middle East & Africa Radiopharmaceutical Sales Forecast by Country (2021-2026) & (M Doses)

Table 80. Middle East & Africa Radiopharmaceutical Revenue Forecast by Country (2021-2026) & ($ millions)

Table 81. Global Radiopharmaceutical Sales Forecast by Type (2021-2026) & (M Doses)

Table 82. Global Radiopharmaceutical Sales Market Share Forecast by Type (2021-2026)

Table 83. Global Radiopharmaceutical Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 84. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2021-2026)

Table 85. Global Radiopharmaceutical Sales Forecast by Application (2021-2026) & (M Doses)

Table 86. Global Radiopharmaceutical Sales Market Share Forecast by Application (2021-2026)

Table 87. Global Radiopharmaceutical Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 88. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2021-2026)

Table 89. Bracco Imaging Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 90. Bracco Imaging Radiopharmaceutical Product Offered

Table 91. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 92. Bracco Imaging Main Business

Table 93. Bracco Imaging Latest Developments

Table 94. Bayer Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 95. Bayer Radiopharmaceutical Product Offered

Table 96. Bayer Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 97. Bayer Main Business

Table 98. Bayer Latest Developments

Table 99. Mallinckrodt Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 100. Mallinckrodt Radiopharmaceutical Product Offered

Table 101. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 102. Mallinckrodt Main Business

Table 103. Mallinckrodt Latest Developments

Table 104. Nordion Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 105. Nordion Radiopharmaceutical Product Offered

Table 106. Nordion Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 107. Nordion Main Business

Table 108. Nordion Latest Developments

Table 109. Triad Isotopes Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 110. Triad Isotopes Radiopharmaceutical Product Offered

Table 111. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 112. Triad Isotopes Main Business

Table 113. Triad Isotopes Latest Developments

Table 114. Lantheus Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 115. Lantheus Radiopharmaceutical Product Offered

Table 116. Lantheus Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 117. Lantheus Main Business

Table 118. Lantheus Latest Developments

Table 119. IBA Group Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 120. IBA Group Radiopharmaceutical Product Offered

Table 121. IBA Group Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 122. IBA Group Main Business

Table 123. IBA Group Latest Developments

Table 124. GE Healthcare Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 125. GE Healthcare Radiopharmaceutical Product Offered

Table 126. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 127. GE Healthcare Main Business

Table 128. GE Healthcare Latest Developments

Table 129. China Isotope & Radiation Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 130. China Isotope & Radiation Radiopharmaceutical Product Offered

Table 131. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 132. China Isotope & Radiation Main Business

Table 133. China Isotope & Radiation Latest Developments

Table 134. Jubilant Pharma Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 135. Jubilant Pharma Radiopharmaceutical Product Offered

Table 136. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 137. Jubilant Pharma Main Business

Table 138. Jubilant Pharma Latest Developments

Table 139. Eli Lilly Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 140. Eli Lilly Radiopharmaceutical Product Offered

Table 141. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 142. Eli Lilly Main Business

Table 143. Eli Lilly Latest Developments

Table 144. Advanced Accelerator Applications Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 145. Advanced Accelerator Applications Radiopharmaceutical Product Offered

Table 146. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 147. Advanced Accelerator Applications Main Business

Table 148. Advanced Accelerator Applications Latest Developments

Table 149. SIEMENS Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 150. SIEMENS Radiopharmaceutical Product Offered

Table 151. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 152. SIEMENS Main Business

Table 153. SIEMENS Latest Developments

Table 154. Dongcheng Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 155. Dongcheng Radiopharmaceutical Product Offered

Table 156. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 157. Dongcheng Main Business

Table 158. Dongcheng Latest Developments

Table 159. Navidea Basic Information, Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors

Table 160. Navidea Radiopharmaceutical Product Offered

Table 161. Navidea Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 162. Navidea Main Business

Table 163. Navidea Latest Developments

List of Figures

Figure 1. Picture of Radiopharmaceutical

Figure 2. Radiopharmaceutical Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Radiopharmaceutical Sales Growth Rate 2016-2026 (M Doses)

Figure 7. Global Radiopharmaceutical Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Radiopharmaceutical Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Actinium-225

Figure 10. Product Picture of Lutetium-177

Figure 11. Product Picture of Radium-223

Figure 12. Product Picture of Holmium-166

Figure 13. Product Picture of Other

Figure 14. Global Radiopharmaceutical Sales Market Share by Type in 2020

Figure 15. Global Radiopharmaceutical Revenue Market Share by Type (2016-2021)

Figure 16. Radiopharmaceutical Consumed in Oncology

Figure 17. Global Radiopharmaceutical Market: Oncology (2016-2021) & (M Doses)

Figure 18. Radiopharmaceutical Consumed in Cardiology

Figure 19. Global Radiopharmaceutical Market: Cardiology (2016-2021) & (M Doses)

Figure 20. Radiopharmaceutical Consumed in Other

Figure 21. Global Radiopharmaceutical Market: Other (2016-2021) & (M Doses)

Figure 22. Global Radiopharmaceutical Sales Market Share by Application (2016-2021)

Figure 23. Global Radiopharmaceutical Revenue Market Share by Application in 2020

Figure 24. Radiopharmaceutical Revenue Market by Company in 2020 ($ Million)

Figure 25. Global Radiopharmaceutical Revenue Market Share by Company in 2020

Figure 26. Global Radiopharmaceutical Sales Market Share by Regions (2016-2021)

Figure 27. Global Radiopharmaceutical Revenue Market Share by Region in 2020

Figure 28. Americas Radiopharmaceutical Sales 2016-2021 (M Doses)

Figure 29. Americas Radiopharmaceutical Revenue 2016-2021 ($ Millions)

Figure 30. APAC Radiopharmaceutical Sales 2016-2021 (M Doses)

Figure 31. APAC Radiopharmaceutical Revenue 2016-2021 ($ Millions)

Figure 32. Europe Radiopharmaceutical Sales 2016-2021 (M Doses)

Figure 33. Europe Radiopharmaceutical Revenue 2016-2021 ($ Millions)

Figure 34. Middle East & Africa Radiopharmaceutical Sales 2016-2021 (M Doses)

Figure 35. Middle East & Africa Radiopharmaceutical Revenue 2016-2021 ($ Millions)

Figure 36. Americas Radiopharmaceutical Sales Market Share by Country in 2020

Figure 37. Americas Radiopharmaceutical Revenue Market Share by Country in 2020

Figure 38. Americas Radiopharmaceutical Sales Market Share by Type in 2020

Figure 39. Americas Radiopharmaceutical Sales Market Share by Application in 2020

Figure 40. United States Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 41. Canada Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 42. Mexico Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 43. Brazil Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 44. APAC Radiopharmaceutical Sales Market Share by Region in 2020

Figure 45. APAC Radiopharmaceutical Revenue Market Share by Regions in 2020

Figure 46. APAC Radiopharmaceutical Sales Market Share by Type in 2020

Figure 47. APAC Radiopharmaceutical Sales Market Share by Application in 2020

Figure 48. China Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 49. Japan Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 50. Korea Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 51. Southeast Asia Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 52. India Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 53. Australia Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 54. Europe Radiopharmaceutical Sales Market Share by Country in 2020

Figure 55. Europe Radiopharmaceutical Revenue Market Share by Country in 2020

Figure 56. Europe Radiopharmaceutical Sales Market Share by Type in 2020

Figure 57. Europe Radiopharmaceutical Sales Market Share by Application in 2020

Figure 58. Germany Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 59. France Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 60. UK Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 61. Italy Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 62. Russia Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 63. Middle East & Africa Radiopharmaceutical Sales Market Share by Country in 2020

Figure 64. Middle East & Africa Radiopharmaceutical Revenue Market Share by Country in 2020

Figure 65. Middle East & Africa Radiopharmaceutical Sales Market Share by Type in 2020

Figure 66. Middle East & Africa Radiopharmaceutical Sales Market Share by Application in 2020

Figure 67. Egypt Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 68. South Africa Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 69. Israel Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 70. Turkey Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 71. GCC Country Radiopharmaceutical Revenue Growth 2016-2021 ($ Millions)

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles